Shopping Cart
Remove All
Your shopping cart is currently empty
Adebrelimab
😃Good
Catalog No. T76899Cas No. 2247114-85-6
Alias SHR-1316, SHR1316, HTI-1316, HTI1316, HTI-1088, HTI1088
Adebrelimab (SHR-1316) is a humanized monoclonal antibody targeting PD-L1 with antitumor activity for the study of solid tumors.
Adebrelimab
Adebrelimab
😃Good
Catalog No. T76899Alias SHR-1316, SHR1316, HTI-1316, HTI1316, HTI-1088, HTI1088Cas No. 2247114-85-6
Adebrelimab (SHR-1316) is a humanized monoclonal antibody targeting PD-L1 with antitumor activity for the study of solid tumors.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | In Stock | In Stock | |
| 5 mg | $645 | In Stock | In Stock | |
| 10 mg | $987 | - | In Stock | |
| 25 mg | $1,530 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock | |
| 100 mg | $2,790 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:97.8% (SDS-PAGE); 97.5% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Adebrelimab (SHR-1316) is a humanized monoclonal antibody targeting PD-L1 with antitumor activity for the study of solid tumors. |
| In vitro | Adebrelimab (0.06-1 mg/mL; treated for 48 hours) significantly inhibited the proliferation, migration, and invasion of SK-BR-3 and AU565 cells. [1] Adebrelimab (0.1-1 mg/mL; 48 hrs) decreased the expression of PD-L1, p-PI3K, and p-AKT, and increased the expression of FOXO1. [1] |
| In vivo | Adebrelimab (200 μg; administered 3 times per week for 21 days) showed significant inhibition of tumor growth. [1] |
| Synonyms | SHR-1316, SHR1316, HTI-1316, HTI1316, HTI-1088, HTI1088 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | B7-H1/PD-L1/CD274 |
| Molecular Weight | 145.54 kDa |
| Cas No. | 2247114-85-6 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG4 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Adebrelimab | purchase Adebrelimab | Adebrelimab cost | order Adebrelimab | Adebrelimab in vivo | Adebrelimab in vitro | Adebrelimab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.